Immunic_July_2021_661_71661

Loading viewer...

investor_presentation

Format: PDF investor_presentation

This document provides an update on the preclinical and clinical development of Immunic's product candidates, including IMU-935, highlighting future plans and risks.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Immunic

View all →

20211006_Immunic_2021%20Virtual%20B%26T%20cell%20mediated%20Autoimmune%20disease%20drug%20development%20summit_Final

presentation

20230707_Immunic_PosterPitchTalk_Mucosal%20Immunolgy%20Meeting-final

presentation

Similar investor_presentations from other companies

Browse all →

Science Applications International Investor Presentation — March 2022

investor_presentation

20 Pages

Science Applications International Corporation

ePlus Inc. Investor Presentation February 2025

investor_presentation